Patient Stratification using Clinical Proteomics – Validated multiplexed MRM assays to quantify HER2 and other biomarkers in clinical FFPE tissues

Home > Science Hub > Patient Stratification using Clinical Proteomics – Validated multiplexed MRM assays to quantify HER2 and other biomarkers in clinical FFPE tissues
Back to the list

November 9, 2020

Maxim Isabelle, Michael Schirm, Gwenaël Pottiez, Rudolf Guilbaud and Lorella Di Donato

Patient Stratification using Clinical Proteomics – Validated multiplexed MRM assays to quantify HER2 and other biomarkers in clinical FFPE tissues, SITC 2020

Capion_Poster_SITC_FFPE

 

Download the poster

You might also be interested by

Webinars

Precision Oncology Approaches: Using Proteomics to Build Next-Gen Diagnostic Solutions

May 2, 2023

Proteomics/Mass Spectrometry

More info

Posters

Analytical characterization of a multiplex panel measuring 45 cytokines by proximity extension assay in plasma from subjects with NSCLC

April 17, 2023

Proteomics/Mass Spectrometry

More info

Brochures

Empower Cancer Research with Proteomics

April 11, 2023

Proteomics/Mass Spectrometry

More info

Infographics

Supporting Your Targeted Protein Degradation Strategies

January 31, 2023

Proteomics/Mass Spectrometry

More info